TN HB1737 | 2023-2024 | 113th General Assembly

Status

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on January 9 2024 - 25% progression, died in chamber
Action: 2024-01-11 - Assigned to s/c Insurance Subcommittee
Text: Latest bill text (Draft #1) [PDF]

Summary

As introduced, caps the total amount that a health insurance carrier can require a covered patient with diabetes to pay for a 30-day supply of insulin at no more than $35; caps the total price that a person who supplies prescription insulin drugs into or within this state for use by a patient with diabetes can charge for a 30-day supply of insulin at no more than $35. - Amends TCA Title 8; Title 53; Title 56, Chapter 7; Title 63 and Title 71, Chapter 5.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

AN ACT to amend Tennessee Code Annotated, Title 8; Title 53; Title 56, Chapter 7; Title 63 and Title 71, Chapter 5, relative to insulin.

Sponsors


History

DateChamberAction
2024-01-11HouseAssigned to s/c Insurance Subcommittee
2024-01-11HouseP2C, ref. to Insurance Committee
2024-01-10HouseIntro., P1C.
2024-01-09HouseFiled for introduction

Same As/Similar To

SB1683 (Crossfiled) 2024-02-20 - Failed in Senate Commerce and Labor Committee - no second

Subjects


Tennessee State Sources


Bill Comments

feedback